TCM
BIS icon

Tradewinds Capital Management’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Tradewinds Capital Management’s Portfolio BIS Stock Details BIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-9
Closed -$2K – 645
2015
Q2 		$2K Buy
+9
New +$2.23K ﹤0.01% 569

Other funds holding BIS

HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CAM
Chesapeake Asset Management New York $126M AUM 36.76% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

Tradewinds Capital Management's BIS Position: Q3 2015 in Review

Tradewinds Capital Management sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q3 2015, closing a stake of 9 shares — an estimated $2K sold.

Tradewinds Capital Management first reported a position in BIS in Q2 2015 and held it in 1 quarter. The position peaked at $2K in Q2 2015. 19 funds tracked by Wall St. Rank hold BIS as of Q3 2015.

  • Tradewinds Capital Management reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q3 2015 after selling out during the quarter.
  • Tradewinds Capital Management sold 9 ProShares UltraShort NASDAQ Biotechnology shares in Q3 2015, an estimated $2K.
  • Tradewinds Capital Management first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q2 2015 and held it in 1 quarter.
  • Tradewinds Capital Management's ProShares UltraShort NASDAQ Biotechnology position peaked at $2K in Q2 2015.
  • 19 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q3 2015.

Based on Tradewinds Capital Management's 13F filing for Q3 2015, filed 2 Nov 2015.